80 results found.
2Q14 Revenue: Alphatec Spine
$53.2MM, +4% (U.S. $34.5MM, +6%; ex-U.S. $18.6MM, +1%) Less-invasive solutions +16%, driven by strong global uptake of Illico MIS Biologics +25% Initiated U.S. beta launch of Arsenal fixation system: ergonomic instrumentation + low-profile impl...
BARE BONES® - May 1, 2014
Alphatec Spine reported 1Q14 revenue of US $49.2MM, -1% from 1Q13. (U.S. $32.1MM, -3%; Ex-U.S. $17.1MM, +3%) (
1Q14 Revenue: Alphatec Spine
$49.2MM, -1% (U.S. $32.1MM, -3%; Ex-U.S. $17.1MM, +3%: Japan +20%) Overall growth impacted by exit from France, overly high procedure cancellations due to poor U.S. weather U.S. hospital non-biologic implant volume +15%, driven by Novel, Solus, Zodiac Deformi...
BARE BONES® - March 18, 2014
Alphatec Spine posted 4Q13 revenue of US $53.1MM, +3.4% from 4Q12, and 2013 revenue of $204.7MM, +7.3% from 2012.  (
4Q13/2013 Revenue: Alphatec Spine
4Q13 revenue: $53.1MM, +3% (U.S. $35.7MM, +5%; ex-U.S. $17.4MM, +1%) Excluding PureGen revenue from 2012, U.S. revenue +11% Minimally invasive portfolio +26% U.S. hospital non-biologic revenue +20% Ex-U.S. sales impacted...
BARE BONES® - February 21, 2014
Alphatec Spine will postpone release of its 4Q13 and 2013 financial results until 3/17/14, allowing time to fully explore options available following the recent verdict in the OrthoTec...
BARE BONES® - November 7, 2013
Alphatec Spine reported 3Q13 revenue of US $50.2MM, +11% vs 3Q12. (U.S. $33.7MM, +9%; ex-U.S. $16.5MM, +14%) Growth reflects constant currency. (
3Q13 Revenue: Alphatec Spine
$50.2MM, +11% (U.S. $33.7MM, +9%; ex-U.S. $16.5MM, +14%, Japan +21%) U.S. hospital non-biologics implant revenue +23% Biologics +15%, excluding PureGen U.S. growth attributed to unit volume gains in core hospital business, increased surgeon upt...
Web Exclusive: Highlights from THE SPINE MARKET report
In 2012, revenues generated by global sales of spinal implants and instrumentation reached an estimated $7.35 billion. Though historic double-digit growth in the segment flattened in 2010, looking ahead, conservative increases should occur based upon a shift in focus to more cervical discs, la...
BARE BONES® - August 6, 2013
Alphatec Spine reported 2Q13 revenue of US $51.0MM, +9% from 2Q12. (U.S. $32.5MM, -1%; ex-U.S. $18.5MM, +30%) (Growth reflects constant currency.) (
2Q13 Revenue: Alphatec Spine
$51.0MM, +9% (U.S. $32.5MM, -1%; ex-U.S. $18.5MM, +30%; Japan +30% constant currency, +5% reported) Japan remains largest ex-U.S. business region, driven by ILLICO MIS products, new Novel interbody devices Metal implant unit sales to U.S. hospitals +10% in li...
BARE BONES® - April 30, 2013
Alphatec Spine reported 1Q13 revenue of US $50.4MM, +6.4% from 1Q12. (U.S. $33.1MM, +1.5%; Ex-U.S. $17.4MM, +16.4%) (
1Q13 Revenue: Alphatec Spine
$50.4MM, +6% (U.S. $33.1MM, +2%; Ex-U.S. $17.4MM, +16%; Japanese subsidiary +9%; Phygen $2MM) Good reception for Pegasus anchored anterior cervical interbody device Market interest growing for Solus anterior lumbar interbody fusion device PureG...
BARE BONES® - February 28, 2013
Alphatec Spine posted 4Q12 revenue of US $52.7MM, +8% from 4Q11, and 2012 revenue of $196.2MM, -0.7% from 2011. 4Q12 growth reflects constant currency. (
4Q12 and 2012 Revenue: Alphatec Spine
$196.3MM, +1% (U.S. $130.5MM, -3%; ex-U.S. $65.8MM, +7%: Japan ~$29MM, +>20%) 4Q12 revenue: $52.7MM, +8% (U.S. $34MM, +4%; ex-U.S. $18.7MM, +16%) Highlights pertain to 4Q12, unless otherwise noted. U.S. hospital pricing relatively sta...
3Q12 Earnings: Alphatec Spine
$47.8MM, flat (U.S. $31.0MM, -5%; ex-U.S. $16.8MM, +12%) Launched BridgePoint spinous process fixation system, NEXoss synthetic bone growth biologic Acquisition of certain Phygen assets will bring access to >100 U.S. spine surgeons and the Leucadia AutoLok Pe...
BARE BONES® - November 5, 2012
Alphatec reported 3Q12 revenue of US $47.8MM, flat vs 3Q11. (U.S. $31.0MM, -5%; ex-U.S. $16.8MM, +12%) Growth reflects constant currency. (
BARE BONES® - October 23, 2012
Alphatec Spine reported preliminary 3Q12 revenue of US $47.8MM (U.S. $31MM, ex-U.S. $16.8MM). (
2Q12: A First Look at Earnings
ORTHOWORLD’s estimates place preliminary 2Q12 market growth at 5% over 2Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 2Q12, unless otherwise noted. Exhibit 1 Orthopaedic Sales Increas...
BARE BONES® - August 7, 2012
Alphatec (ATEC) reported 2Q12 revenue of US $48.2MM, -4% from 2Q11. (U.S. $32.8MM, -5%; ex-U.S. $15.3MM, -1%) During 2Q, ATEC acquired exclusive U.S. distribution rights to a synthetic...
Final 1Q12 Results
ORTHOWORLD’s estimates place overall 1Q12 market growth at 4% over 1Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 1Q12, unless noted otherwise. Exhibit 1 Orthopaedic Sales1 Increas...
BARE BONES® - May 8, 2012
Alphatec Spine reported 1Q12 revenue of US $48.4MM, -3% from 1Q11. (U.S. $32.5MM, -4%; Ex-U.S.  $15.9MM, flat) (
Continuing 2011 Results, Including AAOS Conference Highlights
The orthopaedic industry appears to be tilting its focus from implant materials and toward implant alignment and personalization, per analyst review of the 2012 meeting of the American Academy of Orthopaedic Surgeons (AAOS). On the floor and in recent earnings calls, companies noted observatio...
BARE BONES® - February 28, 2012
Alphatec Spine posted 4Q11 revenue of US $49.5MM, +7% from 4Q10, and 2011 revenue of $197.7MM, +6% from 2010. Growth reflects constant currency. (
3Q11: A First Look at Financials: Alphatec Spine
ALPHATEC SPINE (pro forma) $47.6MM, +3% (U.S. $32.7MM, +9%; ex-U.S. $14.9MM, -8%)    * Greater than expected slowdown in procedure volume * U.S. pricing stable for past 2 quarters, low single-digit decline year over year * Growth propelled b...
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group